In October, Britain agreed a deal with Merck to secure 480,000 courses of molnupiravir. Photo: Reuters
Britain is first to approve Merck’s Covid-19 pill molnupiravir
- The country’s drug regulator recommended molnupiravir be used within five days of the onset of symptoms
- Health minister Sajid Javid said the government would set out plans to deploy the drug to patients through a national study as soon as possible
In October, Britain agreed a deal with Merck to secure 480,000 courses of molnupiravir. Photo: Reuters